15,244 Shares in Medical Properties Trust, Inc. (MPW) Acquired by Vident Investment Advisory LLC

Vident Investment Advisory LLC bought a new stake in Medical Properties Trust, Inc. (NYSE:MPW) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 15,244 shares of the real estate investment trust’s stock, valued at approximately $200,000.

A number of other institutional investors have also recently bought and sold shares of MPW. BB&T Securities LLC raised its position in shares of Medical Properties Trust by 0.3% during the second quarter. BB&T Securities LLC now owns 31,541 shares of the real estate investment trust’s stock worth $405,000 after acquiring an additional 102 shares during the last quarter. Southeast Asset Advisors Inc. raised its position in shares of Medical Properties Trust by 1.7% during the second quarter. Southeast Asset Advisors Inc. now owns 12,824 shares of the real estate investment trust’s stock worth $165,000 after acquiring an additional 216 shares during the last quarter. TD Asset Management Inc. raised its position in shares of Medical Properties Trust by 0.9% during the second quarter. TD Asset Management Inc. now owns 26,676 shares of the real estate investment trust’s stock worth $343,000 after acquiring an additional 233 shares during the last quarter. Suntrust Banks Inc. raised its position in shares of Medical Properties Trust by 1.5% during the second quarter. Suntrust Banks Inc. now owns 30,649 shares of the real estate investment trust’s stock worth $393,000 after acquiring an additional 455 shares during the last quarter. Finally, Fagan Associates Inc. raised its position in shares of Medical Properties Trust by 1.1% during the second quarter. Fagan Associates Inc. now owns 55,896 shares of the real estate investment trust’s stock worth $719,000 after acquiring an additional 626 shares during the last quarter. Hedge funds and other institutional investors own 81.20% of the company’s stock.

Shares of Medical Properties Trust, Inc. (MPW) opened at $13.55 on Friday. Medical Properties Trust, Inc. has a one year low of $11.90 and a one year high of $14.22. The company has a market capitalization of $4,930.00, a P/E ratio of 10.74, a P/E/G ratio of 1.85 and a beta of 0.96. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.55 and a current ratio of 2.55.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 EPS for the quarter, topping the consensus estimate of $0.32 by $0.01. Medical Properties Trust had a return on equity of 7.36% and a net margin of 39.95%. The business had revenue of $176.60 million during the quarter, compared to analysts’ expectations of $172.57 million. During the same quarter last year, the firm posted $0.30 earnings per share. The firm’s revenue was up 39.5% on a year-over-year basis. analysts forecast that Medical Properties Trust, Inc. will post 1.33 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 11th. Shareholders of record on Thursday, December 7th will be paid a $0.24 dividend. The ex-dividend date is Wednesday, December 6th. This represents a $0.96 dividend on an annualized basis and a yield of 7.08%. Medical Properties Trust’s dividend payout ratio (DPR) is presently 126.32%.

A number of brokerages have recently issued reports on MPW. J P Morgan Chase & Co upgraded Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price objective for the company in a research report on Friday, December 15th. ValuEngine raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. KeyCorp reaffirmed a “hold” rating on shares of Medical Properties Trust in a research note on Sunday, September 17th. SunTrust Banks reaffirmed a “buy” rating and set a $15.00 target price on shares of Medical Properties Trust in a research note on Friday, November 3rd. Finally, Zacks Investment Research raised Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a research note on Tuesday, October 24th. Six research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $14.55.

TRADEMARK VIOLATION WARNING: This piece of content was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/12/22/15244-shares-in-medical-properties-trust-inc-mpw-acquired-by-vident-investment-advisory-llc.html.

About Medical Properties Trust

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

What are top analysts saying about Medical Properties Trust? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Medical Properties Trust and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit